Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)
Top Cited Papers
- 15 February 2005
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 95 (4), 462-468
- https://doi.org/10.1016/j.amjcard.2004.10.012
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- High density lipoproteins (HDLs) and atherosclerosis; the unanswered questionsAtherosclerosis, 2003
- Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndromeThe American Journal of Cardiology, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery DiseaseCirculation, 2000
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolThe New England Journal of Medicine, 1999
- Interval estimation for the difference between independent proportions: comparison of eleven methodsStatistics in Medicine, 1998
- Small LDL, Atherogenic Dyslipidemia, and the Metabolic SyndromeCirculation, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsThe New England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaThe New England Journal of Medicine, 1995
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988